vs
Foghorn Therapeutics Inc.（FHTX）与FVCBankcorp, Inc.（FVCB）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是Foghorn Therapeutics Inc.的1.8倍（$16.9M vs $9.2M），FVCBankcorp, Inc.同比增速更快（4377.5% vs 223.8%），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs 35.3%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
FHTX vs FVCB — 直观对比
营收规模更大
FVCB
是对方的1.8倍
$9.2M
营收增速更快
FVCB
高出4153.7%
223.8%
两年增速更快
FVCB
近两年复合增速
35.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $16.9M |
| 净利润 | $-21.7M | — |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 43.7% |
| 净利率 | -234.3% | — |
| 营收同比 | 223.8% | 4377.5% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $-0.35 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXFVCB
| Q4 25 | $9.2M | $16.9M | ||
| Q3 25 | $8.2M | $416.0K | ||
| Q2 25 | $7.6M | $15.8M | ||
| Q1 25 | $6.0M | $382.0K | ||
| Q4 24 | $2.9M | $378.0K | ||
| Q3 24 | $7.8M | $412.0K | ||
| Q2 24 | $6.9M | $415.0K | ||
| Q1 24 | $5.0M | $359.0K |
净利润FHTXFVCB
| Q4 25 | $-21.7M | — | ||
| Q3 25 | $-15.8M | $5.6M | ||
| Q2 25 | $-17.9M | $5.7M | ||
| Q1 25 | $-18.8M | $5.2M | ||
| Q4 24 | $-19.5M | — | ||
| Q3 24 | $-19.1M | $4.7M | ||
| Q2 24 | $-23.0M | $4.2M | ||
| Q1 24 | $-25.0M | $1.3M |
营业利润率FHTXFVCB
| Q4 25 | -258.2% | 43.7% | ||
| Q3 25 | -226.9% | — | ||
| Q2 25 | -279.2% | 45.9% | ||
| Q1 25 | -385.0% | — | ||
| Q4 24 | -840.5% | — | ||
| Q3 24 | -305.5% | — | ||
| Q2 24 | -386.6% | — | ||
| Q1 24 | -558.3% | — |
净利率FHTXFVCB
| Q4 25 | -234.3% | — | ||
| Q3 25 | -194.4% | 1341.1% | ||
| Q2 25 | -237.3% | 36.0% | ||
| Q1 25 | -316.4% | 1352.1% | ||
| Q4 24 | -682.9% | — | ||
| Q3 24 | -244.9% | 1133.3% | ||
| Q2 24 | -333.6% | 1001.2% | ||
| Q1 24 | -495.4% | 373.3% |
每股收益（稀释后）FHTXFVCB
| Q4 25 | $-0.35 | $0.31 | ||
| Q3 25 | $-0.25 | $0.31 | ||
| Q2 25 | $-0.28 | $0.31 | ||
| Q1 25 | $-0.30 | $0.28 | ||
| Q4 24 | $-0.23 | $0.27 | ||
| Q3 24 | $-0.31 | $0.25 | ||
| Q2 24 | $-0.45 | $0.23 | ||
| Q1 24 | $-0.59 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $253.6M |
| 总资产 | $198.1M | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXFVCB
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | — | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $79.3M | — |
股东权益FHTXFVCB
| Q4 25 | $-108.5M | $253.6M | ||
| Q3 25 | $-89.7M | $249.8M | ||
| Q2 25 | $-76.7M | $243.2M | ||
| Q1 25 | $-61.7M | $242.3M | ||
| Q4 24 | $-45.5M | $235.4M | ||
| Q3 24 | $-28.3M | $230.8M | ||
| Q2 24 | $-14.3M | $226.5M | ||
| Q1 24 | $-97.5M | $220.7M |
总资产FHTXFVCB
| Q4 25 | $198.1M | $2.3B | ||
| Q3 25 | $205.0M | $2.3B | ||
| Q2 25 | $226.2M | $2.2B | ||
| Q1 25 | $258.7M | $2.2B | ||
| Q4 24 | $284.0M | $2.2B | ||
| Q3 24 | $308.4M | $2.3B | ||
| Q2 24 | $328.6M | $2.3B | ||
| Q1 24 | $255.0M | $2.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $23.9M |
| 自由现金流经营现金流 - 资本支出 | — | $23.8M |
| 自由现金流率自由现金流/营收 | — | 140.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $40.0M |
8季度趋势，按日历期对齐
经营现金流FHTXFVCB
| Q4 25 | $-22.3M | $23.9M | ||
| Q3 25 | $-18.9M | $7.6M | ||
| Q2 25 | $-21.0M | $3.3M | ||
| Q1 25 | $-24.0M | $5.4M | ||
| Q4 24 | $-24.5M | $18.2M | ||
| Q3 24 | $-21.0M | $4.7M | ||
| Q2 24 | $-25.5M | $1.6M | ||
| Q1 24 | $-29.3M | $7.2M |
自由现金流FHTXFVCB
| Q4 25 | — | $23.8M | ||
| Q3 25 | — | $7.6M | ||
| Q2 25 | $-21.0M | $3.3M | ||
| Q1 25 | $-24.0M | $5.4M | ||
| Q4 24 | $-25.0M | $18.1M | ||
| Q3 24 | $-21.3M | $4.6M | ||
| Q2 24 | $-25.6M | $1.5M | ||
| Q1 24 | $-29.4M | $7.1M |
自由现金流率FHTXFVCB
| Q4 25 | — | 140.7% | ||
| Q3 25 | — | 1818.0% | ||
| Q2 25 | -278.2% | 20.8% | ||
| Q1 25 | -403.2% | 1413.6% | ||
| Q4 24 | -875.3% | 4786.0% | ||
| Q3 24 | -273.0% | 1121.8% | ||
| Q2 24 | -371.0% | 361.2% | ||
| Q1 24 | -583.1% | 1988.3% |
资本支出强度FHTXFVCB
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.5% | 4.2% | ||
| Q4 24 | 16.8% | 37.3% | ||
| Q3 24 | 4.0% | 14.1% | ||
| Q2 24 | 0.2% | 12.8% | ||
| Q1 24 | 2.0% | 3.9% |
现金转化率FHTXFVCB
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
